EUVIMEDEUVIMED entdecken
Crossref

Synergistic therapeutic effect of parecoxib and ilomastat combination in osteoarthritis via inhibition of IL-17/PI3K/AKT/NF-κB activity

Xiaofei Feng, Yao Ma, Yuhao Zhao, Zhenrui Zhao, Zhengdong Song, Li Lin, Wenji Wang

Molecular Immunology · 2025

DOI: 10.1016/j.molimm.2025.02.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Immunology, 2025. Verfasst von Xiaofei Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China. Hauptthemen laut MEDLINE: Osteoarthritis, Isoxazoles, Interleukin-17. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Lanzhou University First Affiliated Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Osteoarthritis is a degenerative disease, and current drug treatment is to give nonsteroidal anti-inflammatory drugs to relieve symptoms. The anti-inflammatory ability of parecoxib and ilomastat has been confirmed, but the synergistic effect of combined administration in osteoarthritis has not been clear. METHODS: Mouse primary chondrocytes stimulated with IL-1β were cultured. The expression levels of inflammatory cytokines and matrix metalloproteinases were investigated by western blotting, quantitative real-time polymerase chain reaction and ELISA. The effects of parecoxib and ilomastat on chondrocyte apoptosis were evaluated by flow cytometry. In addition, the rat model of osteoarthritis was established by meniscal instability, and the morphological changes of cartilage and the expression levels of related molecules were monitored using Safranin O-Fast green and immunohistochemical staining after intra-articular injection of parecoxib, ilomastat, and the combination of the two. RESULTS: In vitro experiments showed that the combined administration of parecoxib and ilomastat more effectively inhibited the expression of proinflammatory factors and matrix metalloproteinases compared with single drug administration. The combined drug treatment could more effectively inhibit IL-1β-induced chondrocyte apoptosis. The combined drug treatment alleviated the progression of osteoarthritis by inhibiting the IL-17/PI3K/AKT/NF-κB pathway. In addition, in vivo experiments showed that the combined administration could improve the further deterioration of the osteoarthritis rat model. CONCLUSIONS: The combined administration of parecoxib and ilomastat to inhibit IL-17/PI3K/AKT/NF-κB transduction is beneficial to reduce the infiltration of inflammatory factors and matrix metalloproteinases in osteoarthritis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoarthritisIsoxazolesInterleukin-17AnimalsNF-kappa BChondrocytesMiceRatsProto-Oncogene Proteins c-aktDrug SynergismSignal TransductionMalePhosphatidylinositol 3-KinasesApoptosisRats, Sprague-DawleyDrug Therapy, CombinationCells, Cultured

Stichwörter der Autor:innen

IL-17IlomastatNF-κBOsteoarthritisPI3KParecoxib

Substanzen

parecoxibNF-kappa BProto-Oncogene Proteins c-aktIsoxazolesInterleukin-17Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China.
  • Clinical Laboratory Center, Gansu Provincial Maternity and Child-Care Hospital, Lanzhou 730000, China.
  • Key Laboratory of Preclinical Study for New Drugs of Gansu Province, Research Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, Institute of Biochemistry and Molecular Biology, School of Basic Med…
  • The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; The First Hospital of Lanzhou University, Lanzhou 730000, China. Electronic address: ldyywjw@163.com.

Förderung

  • Lanzhou University First Affiliated Hospital

Zitieren

APA

Feng, X., Ma, Y., Zhao, Y., Zhao, Z., Song, Z., Lin, L., & Wang, W. (2025). Synergistic therapeutic effect of parecoxib and ilomastat combination in osteoarthritis via inhibition of IL-17/PI3K/AKT/NF-κB activity. Molecular Immunology. https://doi.org/10.1016/j.molimm.2025.02.005

Vancouver

Feng X, Ma Y, Zhao Y, Zhao Z, Song Z, Lin L, et al. Synergistic therapeutic effect of parecoxib and ilomastat combination in osteoarthritis via inhibition of IL-17/PI3K/AKT/NF-κB activity. Molecular Immunology. 2025. doi:10.1016/j.molimm.2025.02.005

BibTeX
@article{Feng2025,
  author = {Feng, Xiaofei and Ma, Yao and Zhao, Yuhao and Zhao, Zhenrui and Song, Zhengdong and Lin, Li and Wang, Wenji},
  title = {Synergistic therapeutic effect of parecoxib and ilomastat combination in osteoarthritis via inhibition of IL-17/PI3K/AKT/NF-κB activity},
  journal = {Molecular Immunology},
  year = {2025},
  doi = {10.1016/j.molimm.2025.02.005}
}
Kostenlos starten →